Medical - Devices
Compare Stocks
4 / 10Stock Comparison
VMD vs BRT vs NHI vs NXRT
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
REIT - Healthcare Facilities
REIT - Residential
VMD vs BRT vs NHI vs NXRT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Devices | REIT - Residential | REIT - Healthcare Facilities | REIT - Residential |
| Market Cap | $353M | $277M | $3.64B | $756M |
| Revenue (TTM) | $287M | $98M | $403M | $252M |
| Net Income (TTM) | $15M | $-12M | $148M | $-32M |
| Gross Margin | 57.5% | 12.6% | 61.3% | 91.1% |
| Operating Margin | 8.2% | 6.1% | 48.5% | 11.5% |
| Forward P/E | 19.2x | — | 22.2x | — |
| Total Debt | $16M | $508M | $1.16B | $1.56B |
| Cash & Equiv. | $14M | $25M | $20M | $14M |
VMD vs BRT vs NHI vs NXRT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Viemed Healthcare, … (VMD) | 100 | 110.6 | +10.6% |
| BRT Apartments Corp. (BRT) | 100 | 130.5 | +30.5% |
| National Health Inv… (NHI) | 100 | 135.3 | +35.3% |
| NexPoint Residentia… (NXRT) | 100 | 93.2 | -6.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VMD vs BRT vs NHI vs NXRT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VMD carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 20.5%, EPS growth 32.1%, 3Y rev CAGR 24.9%
- 413.5% 10Y total return vs BRT's 217.9%
- 20.5% revenue growth vs NXRT's -3.2%
- Lower P/E (19.2x vs 22.2x)
BRT is the #2 pick in this set and the best alternative if defensive is your priority.
- Beta 0.65, yield 7.1%, current ratio 0.86x
- 7.1% yield, vs NXRT's 7.1%, (1 stock pays no dividend)
NHI is the clearest fit if your priority is quality.
- 36.8% margin vs NXRT's -12.7%
NXRT is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 0.62, yield 7.1%
- Lower volatility, beta 0.62, current ratio 0.48x
- Beta 0.62 vs VMD's 0.95
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.5% revenue growth vs NXRT's -3.2% | |
| Value | Lower P/E (19.2x vs 22.2x) | |
| Quality / Margins | 36.8% margin vs NXRT's -12.7% | |
| Stability / Safety | Beta 0.62 vs VMD's 0.95 | |
| Dividends | 7.1% yield, vs NXRT's 7.1%, (1 stock pays no dividend) | |
| Momentum (1Y) | +26.7% vs NXRT's -15.2% | |
| Efficiency (ROA) | 7.5% ROA vs BRT's -1.7%, ROIC 11.6% vs 1.3% |
VMD vs BRT vs NHI vs NXRT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
VMD vs BRT vs NHI vs NXRT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VMD leads in 2 of 6 categories
NHI leads 1 • BRT leads 0 • NXRT leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NHI is the larger business by revenue, generating $403M annually — 4.1x BRT's $98M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to NXRT's -12.7%. On growth, NHI holds the edge at +29.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $287M | $98M | $403M | $252M |
| EBITDAEarnings before interest/tax | $46M | $33M | $282M | $125M |
| Net IncomeAfter-tax profit | $15M | -$12M | $148M | -$32M |
| Free Cash FlowCash after capex | $26M | $16M | $226M | $79M |
| Gross MarginGross profit ÷ Revenue | +57.5% | +12.6% | +61.3% | +91.1% |
| Operating MarginEBIT ÷ Revenue | +8.2% | +6.1% | +48.5% | +11.5% |
| Net MarginNet income ÷ Revenue | +5.2% | -12.5% | +36.8% | -12.7% |
| FCF MarginFCF ÷ Revenue | +9.0% | +16.2% | +56.1% | +31.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.5% | +4.2% | +29.7% | +0.5% |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | -16.7% | +10.8% | 0.0% |
Valuation Metrics
VMD leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 24.9x trailing earnings, NHI trades at a 0% valuation discount to VMD's 24.9x P/E. On an enterprise value basis, VMD's 7.2x EV/EBITDA is more attractive than BRT's 20.3x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $353M | $277M | $3.6B | $756M |
| Enterprise ValueMkt cap + debt − cash | $356M | $760M | $4.8B | $2.3B |
| Trailing P/EPrice ÷ TTM EPS | 24.89x | -22.31x | 24.85x | -23.65x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.19x | — | 22.17x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 7.21x | 20.32x | 17.16x | 18.60x |
| Price / SalesMarket cap ÷ Revenue | 1.31x | 2.86x | 9.61x | 3.01x |
| Price / BookPrice ÷ Book value/share | 2.62x | 1.50x | 2.29x | 2.52x |
| Price / FCFMarket cap ÷ FCF | 29.59x | 25.60x | 16.52x | 9.05x |
Profitability & Efficiency
VMD leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
VMD delivers a 10.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-10 for NXRT. VMD carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), NHI scores 6/9 vs BRT's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.5% | -6.8% | +9.8% | -10.1% |
| ROA (TTM)Return on assets | +7.5% | -1.7% | +5.4% | -1.7% |
| ROICReturn on invested capital | +11.6% | +1.3% | +5.6% | +1.1% |
| ROCEReturn on capital employed | +13.2% | +1.6% | +8.0% | +1.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.11x | 2.87x | 0.76x | 5.18x |
| Net DebtTotal debt minus cash | $2M | $483M | $1.1B | $1.5B |
| Cash & Equiv.Liquid assets | $14M | $25M | $20M | $14M |
| Total DebtShort + long-term debt | $16M | $508M | $1.2B | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | 14.61x | 0.51x | 3.45x | 0.47x |
Total Returns (Dividends Reinvested)
Evenly matched — VMD and NHI each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NHI five years ago would be worth $13,097 today (with dividends reinvested), compared to $7,705 for NXRT. Over the past 12 months, VMD leads with a +26.7% total return vs NXRT's -15.2%. The 3-year compound annual growth rate (CAGR) favors NHI at 20.2% vs NXRT's -5.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +27.6% | +3.5% | -1.1% | +2.6% |
| 1-Year ReturnPast 12 months | +26.7% | +2.7% | +2.8% | -15.2% |
| 3-Year ReturnCumulative with dividends | -14.6% | +1.0% | +73.5% | -15.5% |
| 5-Year ReturnCumulative with dividends | -3.8% | +7.5% | +31.0% | -23.0% |
| 10-Year ReturnCumulative with dividends | +413.5% | +217.9% | +58.9% | +211.1% |
| CAGR (3Y)Annualised 3-year return | -5.1% | +0.3% | +20.2% | -5.5% |
Risk & Volatility
Evenly matched — VMD and NHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than VMD's 0.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VMD currently trades 90.5% from its 52-week high vs NXRT's 77.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | 0.65x | -0.08x | 0.62x |
| 52-Week HighHighest price in past year | $10.18 | $16.69 | $90.94 | $38.30 |
| 52-Week LowLowest price in past year | $5.93 | $13.18 | $68.80 | $23.79 |
| % of 52W HighCurrent price vs 52-week peak | +90.5% | +88.2% | +82.5% | +77.8% |
| RSI (14)Momentum oscillator 0–100 | 34.7 | 56.6 | 28.0 | 71.0 |
| Avg Volume (50D)Average daily shares traded | 312K | 54K | 332K | 216K |
Analyst Outlook
Evenly matched — BRT and NXRT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VMD as "Buy", BRT as "Buy", NHI as "Hold", NXRT as "Hold". Consensus price targets imply 42.6% upside for BRT (target: $21) vs -9.4% for NXRT (target: $27). For income investors, BRT offers the higher dividend yield at 7.13% vs NHI's 4.80%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | — | $21.00 | $85.40 | $27.00 |
| # AnalystsCovering analysts | 1 | 5 | 18 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | +7.1% | +4.8% | +7.1% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 1 | 12 |
| Dividend / ShareAnnual DPS | — | $1.05 | $3.61 | $2.11 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.7% | +1.8% | 0.0% | +1.0% |
VMD leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). NHI leads in 1 (Income & Cash Flow). 3 tied.
VMD vs BRT vs NHI vs NXRT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VMD or BRT or NHI or NXRT a better buy right now?
For growth investors, Viemed Healthcare, Inc.
(VMD) is the stronger pick with 20. 5% revenue growth year-over-year, versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). National Health Investors, Inc. (NHI) offers the better valuation at 24. 9x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate Viemed Healthcare, Inc. (VMD) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VMD or BRT or NHI or NXRT?
On trailing P/E, National Health Investors, Inc.
(NHI) is the cheapest at 24. 9x versus Viemed Healthcare, Inc. at 24. 9x. On forward P/E, Viemed Healthcare, Inc. is actually cheaper at 19. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — VMD or BRT or NHI or NXRT?
Over the past 5 years, National Health Investors, Inc.
(NHI) delivered a total return of +31. 0%, compared to -23. 0% for NexPoint Residential Trust, Inc. (NXRT). Over 10 years, the gap is even starker: VMD returned +413. 5% versus NHI's +58. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VMD or BRT or NHI or NXRT?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 08β versus Viemed Healthcare, Inc. 's 0. 95β — meaning VMD is approximately -1229% more volatile than NHI relative to the S&P 500. On balance sheet safety, Viemed Healthcare, Inc. (VMD) carries a lower debt/equity ratio of 11% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VMD or BRT or NHI or NXRT?
By revenue growth (latest reported year), Viemed Healthcare, Inc.
(VMD) is pulling ahead at 20. 5% versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). On earnings-per-share growth, the picture is similar: Viemed Healthcare, Inc. grew EPS 32. 1% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, VMD leads at 24. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VMD or BRT or NHI or NXRT?
National Health Investors, Inc.
(NHI) is the more profitable company, earning 37. 6% net margin versus -12. 7% for NexPoint Residential Trust, Inc. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus 7. 7% for VMD. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VMD or BRT or NHI or NXRT more undervalued right now?
On forward earnings alone, Viemed Healthcare, Inc.
(VMD) trades at 19. 2x forward P/E versus 22. 2x for National Health Investors, Inc. — 3. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BRT: 42. 6% to $21. 00.
08Which pays a better dividend — VMD or BRT or NHI or NXRT?
In this comparison, BRT (7.
1% yield), NXRT (7. 1% yield), NHI (4. 8% yield) pay a dividend. VMD does not pay a meaningful dividend and should not be held primarily for income.
09Is VMD or BRT or NHI or NXRT better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 8% yield). Both have compounded well over 10 years (NHI: +58. 9%, VMD: +413. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VMD and BRT and NHI and NXRT?
These companies operate in different sectors (VMD (Healthcare) and BRT (Real Estate) and NHI (Real Estate) and NXRT (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VMD is a small-cap high-growth stock; BRT is a small-cap income-oriented stock; NHI is a small-cap income-oriented stock; NXRT is a small-cap income-oriented stock. BRT, NHI, NXRT pay a dividend while VMD does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.